ConductScience.org, home

Paper41009719

Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies.

Ma SJ and 3 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies. Papers, record 41009719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009719

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.38, provisional
iCite
Revised in PubMed
2026-10-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ma SJSi-Jia
2Zhu YTYu-Ting
3He FFFang-Fanghttps://orcid.org/0000-0002-3546-4628
4Zhang CChunhttps://orcid.org/0000-0003-3565-8024

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PodocytesMajor topic
Cellular SenescenceMajor topic
Kidney DiseasesMajor topic
Humans
Animals
Autophagy
Aging

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82370728National Natural Science Foundation of ChinaPubMed
82470771National Natural Science Foundation of ChinaPubMed
82200841National Natural Science Foundation of ChinaPubMed
81974097National Natural Science Foundation of ChinaPubMed
2024YFC3044900National Key Research and Development Program of ChinaPubMed
2023BCB034Key Research and Development Program of Hubei ProvincePubMed
2024AFD083the Innovation and Development Joint Fund of EnshiPubMed
2024HBBHCXB028Hubei Province Postdoctoral Innovative Talent Training ProgramPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in42884184Correction: Ma et al. Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies. Int. J. Mol. Sci. 2025, 26, 9159.https://conductscience.org/library/papers/42884184

Source PubMed

Download CSV of comments and corrections

References192

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136263181Regulation of Podocyte Injury by CircHIPK3/FUS Complex in Diabetic Kidney Disease.Int J Biol Sci2022https://conductscience.org/library/papers/36263181PubMed
226039325Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.Autophagy2015https://conductscience.org/library/papers/26039325PubMed
333850550Metformin attenuates diabetic renal injury via the AMPK-autophagy axis.Exp Ther Med2021https://conductscience.org/library/papers/33850550PubMed
437900001Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis.Kidney Dis (Basel)2023https://conductscience.org/library/papers/37900001PubMed
537507049Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease.Kidney Int2023https://conductscience.org/library/papers/37507049PubMed
633754024GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.Theranostics2021https://conductscience.org/library/papers/33754024PubMed
722301996(Pro)renin receptor and autophagy in podocytes.Autophagy2012https://conductscience.org/library/papers/22301996PubMed
831040292FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.Sci Rep2019https://conductscience.org/library/papers/31040292PubMed
928819100Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy.Sci Rep2017https://conductscience.org/library/papers/28819100PubMed
1023691056Dysregulated autophagy contributes to podocyte damage in Fabry's disease.PLoS One2013https://conductscience.org/library/papers/23691056PubMed
1134163041Senolytics for kidney repair.Nat Rev Nephrol2021https://conductscience.org/library/papers/34163041PubMed
1232792490Podocytopathies.Nat Rev Dis Primers2020https://conductscience.org/library/papers/32792490PubMed
1333321755Metformin Protects against Podocyte Injury in Diabetic Kidney Disease.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33321755PubMed
1431420196Podocyte development, disease, and stem cell research.Kidney Int2019https://conductscience.org/library/papers/31420196PubMed
1536531996Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy.Front Immunol2022https://conductscience.org/library/papers/36531996PubMed
1638504059Obesity-related glomerulopathy is associated with elevated WT1 expression in podocytes.Int J Obes (Lond)2024https://conductscience.org/library/papers/38504059PubMed
1728905451Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development.Stem Cells2017https://conductscience.org/library/papers/28905451PubMed
1835918536Biochemical and mechanical regulation of actin dynamics.Nat Rev Mol Cell Biol2022https://conductscience.org/library/papers/35918536PubMed
1934363464Role of Cellular Senescence in Type II Diabetes.Endocrinology2021https://conductscience.org/library/papers/34363464PubMed
2035716094A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.Acta Physiol (Oxf)2022https://conductscience.org/library/papers/35716094PubMed

See all 192 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42884184Correction: Ma et al. Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies. Int. J. Mol. Sci. 2025, 26, 9159.Int J Mol Sci2026https://conductscience.org/library/papers/42884184PubMed
42575141Podocyte dysfunction in kidney diseases: Mechanisms and therapeutic advances.Sci Prog2026https://conductscience.org/library/papers/42575141PubMed
42224032The Weary Gatekeeper: Podocyte Aging and Glomerular Decline.J Am Soc Nephrol2026https://conductscience.org/library/papers/42224032PubMed
41892341Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases.Cells2026https://conductscience.org/library/papers/41892341PubMed
41597279Targeting SMPDL3B to Ameliorate Radiation- and Cisplatin-Induced Renal Toxicity.Cells2026https://conductscience.org/library/papers/41597279PubMed
41516293miRNA in the Progression of Diabetic Kidney Disease: New Insight.Int J Mol Sci2025https://conductscience.org/library/papers/41516293PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41009719

GET https://conductscience.org/api/papers/v1/41009719/references?page=2